Home/Filings/4/0001209191-17-063711
4//SEC Filing

WRIGHT TIMOTHY MICHAEL 4

Accession 0001209191-17-063711

CIK 0001505512other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 9:31 AM ET

Size

5.6 KB

Accession

0001209191-17-063711

Insider Transaction Report

Form 4
Period: 2017-12-04
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-12-04+100,000100,000 total
    Exercise: $3.30From: 2017-12-04Exp: 2026-10-02Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]On October 3, 2016, the reporting person was granted an option to purchase 400,000 shares of common stock. The option vests in increments of 100,000 shares upon the achievement of certain performance criteria. On December 4, 2017, the performance criteria for the first goal were met, resulting in the vesting of 100,000 shares.

Issuer

Regulus Therapeutics Inc.

CIK 0001505512

Entity typeother

Related Parties

1
  • filerCIK 0001686178

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:31 AM ET
Size
5.6 KB